|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 12400 |
FusionGeneSummary for F3_C11orf80 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: F3_C11orf80 | Fusion gene ID: 12400 | Hgene | Tgene | Gene symbol | F3 | C11orf80 | Gene ID | 2152 | 79703 |
| Gene name | coagulation factor III, tissue factor | chromosome 11 open reading frame 80 | |
| Synonyms | CD142|TF|TFA | TOP6BL|TOPOVIBL | |
| Cytomap | 1p21.3 | 11q13.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | tissue factorcoagulation factor III (thromboplastin, tissue factor) | type 2 DNA topoisomerase 6 subunit B-liketype 2 DNA topoisomerase VI subunit B-like | |
| Modification date | 20180527 | 20180523 | |
| UniProtAcc | P13726 | ||
| Ensembl transtripts involved in fusion gene | ENST00000334047, ENST00000370207, ENST00000480356, | ENST00000346672, ENST00000360962, ENST00000527634, ENST00000540737, ENST00000532565, ENST00000525449, ENST00000527368, | |
| Fusion gene scores | * DoF score | 3 X 3 X 2=18 | 12 X 7 X 8=672 |
| # samples | 4 | 15 | |
| ** MAII score | log2(4/18*10)=1.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(15/672*10)=-2.16349873228288 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: F3 [Title/Abstract] AND C11orf80 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | F3 | GO:0001938 | positive regulation of endothelial cell proliferation | 17898544 |
| Hgene | F3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 17469850 |
| Hgene | F3 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 17898544 |
| Hgene | F3 | GO:0007596 | blood coagulation | 8632006|24998411 |
| Hgene | F3 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 17991872 |
| Hgene | F3 | GO:0016485 | protein processing | 24998411 |
| Hgene | F3 | GO:0045766 | positive regulation of angiogenesis | 17898544 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | HNSC | TCGA-D6-6517-01A | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| TCGA | LD | HNSC | TCGA-F7-A620-01A | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000334047 | ENST00000346672 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| Frame-shift | ENST00000334047 | ENST00000360962 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| Frame-shift | ENST00000334047 | ENST00000527634 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| Frame-shift | ENST00000334047 | ENST00000540737 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| Frame-shift | ENST00000334047 | ENST00000532565 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| Frame-shift | ENST00000334047 | ENST00000525449 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| 5CDS-intron | ENST00000334047 | ENST00000527368 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| Frame-shift | ENST00000370207 | ENST00000346672 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| Frame-shift | ENST00000370207 | ENST00000360962 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| Frame-shift | ENST00000370207 | ENST00000527634 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| Frame-shift | ENST00000370207 | ENST00000540737 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| Frame-shift | ENST00000370207 | ENST00000532565 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| Frame-shift | ENST00000370207 | ENST00000525449 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| 5CDS-intron | ENST00000370207 | ENST00000527368 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| 5UTR-3CDS | ENST00000480356 | ENST00000346672 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| 5UTR-3CDS | ENST00000480356 | ENST00000360962 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| 5UTR-3CDS | ENST00000480356 | ENST00000527634 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| 5UTR-3CDS | ENST00000480356 | ENST00000540737 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| 5UTR-3CDS | ENST00000480356 | ENST00000532565 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| 5UTR-3CDS | ENST00000480356 | ENST00000525449 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
| 5UTR-intron | ENST00000480356 | ENST00000527368 | F3 | chr1 | 95007093 | - | C11orf80 | chr11 | 66583524 | + |
Top |
FusionProtFeatures for F3_C11orf80 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| F3 | C11orf80 |
| Initiates blood coagulation by forming a complex withcirculating factor VII or VIIa. The [TF:VIIa] complex activatesfactors IX or X by specific limited protolysis. TF plays a role innormal hemostasis by initiating the cell-surface assembly andpropagation of the coagulation protease cascade.{ECO:0000269|PubMed:12652293}. | Lectin that binds to various sugars: galactose > mannose= fucose > N-acetylglucosamine > N-acetylgalactosamine(PubMed:10224141). Acts as a chemoattractant, probably involved inthe regulation of cell migration (PubMed:28301481).{ECO:0000269|PubMed:10224141, ECO:0000269|PubMed:28301481}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for F3_C11orf80 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for F3_C11orf80 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| F3 | F7, FLNA, PLG, ELAVL1, DAD1, TM9SF4, RAB13, STX12, UBE2D1, UBE2D2, UBE2D3, UBE2D4, PPP2R4 | C11orf80 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for F3_C11orf80 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | F3 | P13726 | DB00036 | Coagulation factor VIIa Recombinant Human | Tissue factor | biotech | approved |
Top |
RelatedDiseases for F3_C11orf80 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | F3 | C0012739 | Disseminated Intravascular Coagulation | 3 | CTD_human |
| Hgene | F3 | C0040053 | Thrombosis | 2 | CTD_human |
| Hgene | F3 | C0023487 | Acute Promyelocytic Leukemia | 1 | CTD_human |
| Hgene | F3 | C0023890 | Liver Cirrhosis | 1 | CTD_human |
| Hgene | F3 | C0027726 | Nephrotic Syndrome | 1 | CTD_human |
| Hgene | F3 | C0034155 | Purpura, Thrombotic Thrombocytopenic | 1 | CTD_human |
| Hgene | F3 | C0042487 | Venous Thrombosis | 1 | CTD_human |
| Hgene | F3 | C0151744 | Myocardial Ischemia | 1 | CTD_human |
| Hgene | F3 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|